AptaBio Therapeutics Market Cap

AptaBio Therapeutics has a market cap or net worth of 203.76 billion as of June 27, 2025. Its market cap has increased by 60.31% in one year.

Market Cap

203.76B

Enterprise Value

186.81B

Revenue

3.11B

Ranking

n/a

PE Ratio

n/a

Stock Price

7,580.00

Market Cap Chart

Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 203.76B, a decrease of -51.86%. That is a compound annual growth rate of -11.43%.

Market Cap History

Date	Market Cap	% Change
Jun 18, 2025	213.44B	24.65%
Dec 30, 2024	171.23B	-15.15%
Dec 28, 2023	201.80B	-15.02%
Dec 29, 2022	237.48B	-71.24%
Dec 30, 2021	825.71B	46.50%
Dec 30, 2020	563.64B	49.70%
Dec 30, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	70.89T
Celltrion	35.32T
ALTEOGEN	20.33T
Yuhan	7,706.69B
SK Biopharmaceuticals	7,150.00B
HLB Co., Ltd.	6,597.67B
PharmaResearch	5,044.17B
Peptron	4,310.01B

Market Cap Rankings